Navigation Links
Drug Herceptin To Be Recommended To All Breast Cancer Patients

The drug Herceptin is to be recommended for breast cancer patients, who show positive for Her-2/neu. The presence of Her-2/neu indicates that the patient is positive, and they have a more resistant and active breast cancer, // about 30% of breast cancer women are Her-2/neu positive and the treatment for these patients with chemotherapy or anti-estrogen therapy such as Tamoxifen does not show any significant disease reduction. These patients should be given Herceptin drug for treatment.

Health Secretary Patricia Hewitt has already ordered the National Institute for Health and Clinical Excellence (NICE), the drugs watchdog, to fast track its assessment of the wider use of Herceptin. Herceptin targets a protein called HER2, which appears to be over-abundant in some women's breast cancers. Controversy also is occurring over the usage of Herceptin with some believing that Herceptin treatment is only useful during late stage breast cancer treatment, but campaigners and critics say that the drug is useful for also early stage breast cancer patients. Primary care trusts (PCTs) is currently to fund Herceptin treatment for women with early stage breast cancer, if they so wish, but campaigners say lack of funds and official approval mean that many women who could benefit are being denied the drug.

The Government is considering Her-2/neu testing to all breast cancer patients during their breast cancer surgery, using the tissue sample obtained during the surgery procedure. The company, which makes the drug, Roche, says the application for widening the use of Herceptin cannot be made any sooner than February because data from independent research has to be evaluated before it can be submitted. Keywords: Breast cancer, Herceptin, Her-2/neu, treatment, tamoxifen, chemotherapy, anti estrogen therapy, drug, anti-cancer drug, medication, primary care trust, stage of cancer, screening, controversy.
'"/>




Page: 1

Related medicine news :

1. Nurse wins her case over use of Herceptin for her Breast cancer
2. Herceptin Is A Possible Cure For Breast Cancer
3. Herceptin Not A ‘Wonder’ Drug, Says The Lanct
4. £6000 to be refunded to Mrs. Leese for Herceptin treatmen
5. Wangaratta Community fundraising for Herceptin drug
6. Herceptin for Early Stage Breast cancer
7. Treatment of Breast Cancer with Herceptin for Nine Weeks
8. Herceptin is the cure for early stages of breast cancer?
9. 10-year-old Pleads, Herceptin For My Mum, Please
10. Norfolk PCTs To Offer Herceptin
11. Daughter Turns Saviour: Ailing Mother Provided Wonder Drug Herceptin, To Fight Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/24/2017)... Pittsburgh, PA (PRWEB) , ... March 24, 2017 ... ... the Oncology Nursing Society (ONS) wanted to create a communications platform that positions ... realize this goal, Elliance and ONS reinvented their online publication as an always-on, ...
(Date:3/24/2017)... ... March 24, 2017 , ... On June 9, ... Benefit Claims Litigation seminar in Chicago, Illinois. She will present on: , ... cases litigated under ERISA involve claims for long-term disability benefits. This session ...
(Date:3/24/2017)... ... ... Viewers who like to educate themselves on current issues and who enjoy ... societal issues tend to appreciate and love the "Informed" series, hosted by Rob Lowe. ... for causes around the world. , Running for charity has become a ...
(Date:3/24/2017)... ... March 24, 2017 , ... Empower Brokerage, located in ... and leads programs. , In February, 2017, Empower Brokerage introduced their new “Performance ... is designed to teach how to maximize their sales efforts, as well as ...
(Date:3/24/2017)... ... March 24, 2017 , ... “Finding ... God #TruthwithGrace”: a devotional journal chronicling the writer’s path toward true communion with ... Walk with God #TruthwithGrace” is the creation of published author Lea Michelle Johnson, ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... 2017  Eli Lilly and Company (NYSE: ... $850 million in its U.S. operations in 2017. ... enterprise, including research laboratories, manufacturing sites, and general ... by demand for Lilly products, as well as ... targeting cancer, pain, diabetes and other unmet medical ...
(Date:3/24/2017)... Mar 24, 2017 The Board of Directors ... Annual Report 2016 including the complete 2016 Annual Accounts with ... on Nordic Nanovector,s website in the section Investor Relations/Reports and ... ... Tone Kvåle, Chief Financial Officer Cell: +47-91-51-95-76 Email: ir@nordicnanovector.com ...
(Date:3/23/2017)... 2017  Transportation Insight, a multi-modal lead logistics solutions ... management firm with expertise serving clients in the food ... Zaffarano was named a 2017 Food Logistics ... the only publication exclusively dedicated to covering the movement ... "Rick has brought to Transportation Insight a wealth ...
Breaking Medicine Technology: